SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-024334
Filing Date
2022-08-30
Accepted
2022-08-30 06:15:46
Documents
164
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 4828892
2 ex4-12.htm EX-4.12 716349
3 ex12-01.htm EX-12.01 11954
4 ex12-02.htm EX-12.02 11900
5 ex13-01.htm EX-13.01 7112
6 ex13-02.htm EX-13.02 7088
7 ex15-1.htm EX-15.1 3923
8 ex15-2.htm EX-15.2 4061
9 ex15-3.htm EX-15.3 52509
10 ex15-4.htm EX-15.4 1233
11 ex15-5.htm EX-15.5 2963
12 form20-f_001.jpg GRAPHIC 96063
  Complete submission text file 0001493152-22-024334.txt   22031203

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE gene-20220630.xsd EX-101.SCH 133399
14 XBRL CALCULATION FILE gene-20220630_cal.xml EX-101.CAL 114331
15 XBRL DEFINITION FILE gene-20220630_def.xml EX-101.DEF 397747
16 XBRL LABEL FILE gene-20220630_lab.xml EX-101.LAB 711975
17 XBRL PRESENTATION FILE gene-20220630_pre.xml EX-101.PRE 580603
158 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 5563152
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Filer) CIK: 0001166272 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51504 | Film No.: 221212858
SIC: 2836 Biological Products, (No Diagnostic Substances)